Cantor Fitzgerald Reaffirms Overweight on AMD, $135 Price Target

February 5, 2025 Analyst: C.J. Muse 1 min read Reproduced verbatim
Rating
Buy
Unchanged
Target
$135
Outcome
Reached
on June 24, 2025
Cantor and AMD logos

What the analyst said

Cantor Fitzgerald analyst C.J.

Muse reiterated an Overweight rating and $135 price target on AMD (NASDAQ: AMD).

“As for the good news, AMD offered a modest beat and raise for the December/March Qs vs. buyside expectations for a modest miss.

We note Client was the main contributor here (growing 23% Q/Q), enabling overall Client to grow a very healthy 52% in CY24 (can you say x86 share gains??).

On the other hand, Data Center results ($3.86B vs cons $4.1B) and guide ($3.6B vs cons $3.9B) disappointed with mgmt. discussing DC GPU tracking similarly in 1HCY25 to 2HCY24 – which we model at $3.4B.

The good news – mgmt. pulled in the MI350 ramp to mid-2025 vs prior 2HCY25 due to better-than-expected demand and positive customer feedback (with sampling commencing this quarter) and highlighted expectations for total DC GPU revenues to exit CY25 at a solid growth rate vs the CY24 exit rate.

The bad news, we believe this commentary is more in line with our Instinct revenue estimate of $7B for all of CY25 (vs. consensus of total DC growing by $5.9B, suggesting DC CPU growing unlikely 50+%).

Bigger picture, mgmt. is guiding Opex +15-16% Y/Y with a vision for total revenues to grow at a faster rate.

We now model CY25 revenues growing by +21%, below consensus coming in at +24%, but clearly better than our prior estimate of +14%.

Thus, street estimates should come down – we now model EPS of $4.50 for CY25 vs. consensus of $4.88, but we still model accelerated EPS growth into CY26 of $6.00.

Thus, no change to our price target of $135 (equates to 30x/23x CY25/26 EPS estimate). With shares indicated at ~$110 in the after-market and showing 20+% upside, we reiterate our Overweight rating.

Key catalyst – more color on MI350/400 roadmaps and ability for AMD to attain Lisa’s stated “Tens of Billions” in Accelerator revenue in the next few years.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

AMD trades at $529. The 26 analysts who set a target in the last 3 months range from $465 to $1,250, with a median of $680. This $135 target is 80% below the median, the lowest on the Street.

Since the note AMD has moved +342% (from $120). The 12-month window closed on February 5, 2026.

Track record

This call✓ Target reached on June 24, 2025, 5 months after the note.

Firm track recordCantor: 86% of its 28 targets at least a year old were reached within 12 months (#12 of 28 firms); on AMD, 3 of 3. Accuracy ranking →

Cantor on AMD

Cantor price targets on AMD

8 calls from February 5, 2025 to February 2, 2026. The target went from $135 to $350 (+159%). The rating stayed Buy.

Cantor targetAMD share price
  1. February 2, 2026Target raised from $300 (+17%)Buy$350
  2. December 16, 2025Target cut from $350 (−14%)Buy$300
  3. November 12, 2025Kept the $350 targetBuy$350
  4. November 5, 2025Target raised from $140 (+150%)Buy$350
  5. June 13, 2025Kept the $140 targetBuy$140
  6. June 9, 2025Target raised from $120 (+17%)Buy$140
  7. May 7, 2025Target cut from $135 (−11%)Buy$120
  8. February 5, 2025 This noteEarliest call shownBuy$135
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.